Palliative care for in-patient malignant glioma patients in Germany

Larissa Fink,Birgitt van Oorschot,Christiane von Saß,Maxine Dibué,Marie-Therese Foster,Heidrun Golla,Ronald Goldbrunner,Christian Senft,Aaron Lawson McLean,Martin Hellmich,Nazife Dinc,Raymond Voltz,Heiner Melching,Christine Jungk,Marcel A. Kamp
DOI: https://doi.org/10.1007/s11060-024-04611-8
2024-03-21
Journal of Neuro-Oncology
Abstract:Malignant gliomas impose a significant symptomatic burden on patients and their families. Current guidelines recommend palliative care for patients with advanced tumors within eight weeks of diagnosis, emphasizing early integration for malignant glioma cases. However, the utilization rate of palliative care for these patients in Germany remains unquantified. This study investigates the proportion of malignant glioma patients who either died in a hospital or were transferred to hospice care from 2019 to 2022, and the prevalence of in-patient specialized palliative care interventions.
oncology,clinical neurology
What problem does this paper attempt to address?